Avis juridique important

|

31978D0167

78/167/EEC: Council Decision of 13 February 1978 adopting a concerted project of the European Economic Community in the field of registration of congenital abnormalities (medical and public health research)

Official Journal L 052 , 23/02/1978 P. 0020 - 0023

****( 1 ) OJ NO C 299 , 12 . 12 . 1977 , P . 47 .  ( 2 ) OPINION ON 23 AND 24 NOVEMBER 1977 ( NOT YET PUBLISHED IN THE OFFICIAL JOURNAL ).  ( 3 ) OJ NO C 7 , 29 . 1 . 1974 , P . 6 .  ( 4 ) OJ NO C 7 , 29 . 1 . 1974 , P . 2 .    COUNCIL DECISION   OF 13 FEBRUARY 1978   ADOPTING A CONCERTED PROJECT OF THE EUROPEAN ECONOMIC COMMUNITY IN THE FIELD OF REGISTRATION OF CONGENITAL ABNORMALITIES ( MEDICAL AND PUBLIC HEALTH RESEARCH )  ( 78/167/EEC )   THE COUNCIL OF THE EUROPEAN   COMMUNITIES ,   HAVING REGARD TO THE TREATY ESTABLISHING THE EUROPEAN ECONOMIC COMMUNITY , AND IN PARTICULAR ARTICLE 235 THEREOF ,   HAVING REGARD TO THE PROPOSAL FROM THE COMMISSION ,   HAVING REGARD TO THE OPINION OF THE EUROPEAN PARLIAMENT  ( 1 ),   HAVING REGARD TO THE OPINION OF THE ECONOMIC AND SOCIAL COMMITTEE ( 2 ),   WHEREAS , BY VIRTUE OF ARTICLE 2 OF THE TREATY ESTABLISHING THE EUROPEAN ECONOMIC COMMUNITY , THE COMMUNITY HAS BEEN ASSIGNED THE TASK OF PROMOTING THROUGHOUT THE COMMUNITY A HARMONIOUS DEVELOPMENT OF ECONOMIC ACTIVITIES , A CONTINUOUS AND BALANCED EXPANSION AND AN ACCELERATED RAISING OF THE STANDARDS OF LIVING ;   WHEREAS , IN ITS RESOLUTION OF 14 JANUARY 1974 ON AN INITIAL OUTLINE PROGRAMME OF THE EUROPEAN COMMUNITIES IN THE FIELD OF SCIENCE AND TECHNOLOGY ( 3 ), THE COUNCIL STRESSED THAT AN APPROPRIATE APPROACH SHOULD BE ADOPTED TOWARDS THE WHOLE RANGE OF AVAILABLE WAYS AND MEANS , INCLUDING CONCERTED PROJECTS AND THAT WHENEVER IT PROVES DESIRABLE THAT THIRD COUNTRIES , PARTICULARLY EUROPEAN ONES , SHOULD BE ASSOCIATED IN THESE PROJECTS , STEPS SHOULD BE TAKEN TO MAKE THIS POSSIBLE ;   WHEREAS , IN ITS RESOLUTION OF 14 JANUARY 1974 RELATING IN PARTICULAR TO THE COORDINATION OF NATIONAL POLICIES IN THE FIELD OF SCIENCE AND TECHNOLOGY ( 4 ), THE COUNCIL ENTRUSTED THE COMMUNITY INSTITUTIONS WITH THE TASK OF GRADUALLY ENSURING SUCH COORDINATION , AIDED BY THE SCIENTIFIC AND TECHNICAL RESEARCH COMMITTEE ( CREST );   WHEREAS A CONCERTED COMMUNITY RESEARCH ACTION IN THE FIELD OF REGISTRATION OF CONGENITAL ABNORMALITIES IS LIKELY TO CONTRIBUTE EFFECTIVELY TO THE ACHIEVEMENT OF THE ABOVEMENTIONED AIMS ;   WHEREAS THE MEMBER STATES INTEND , AS PART OF THE RULES AND PROCEDURES APPLICABLE TO THEIR NATIONAL PROGRAMMES , TO CARRY OUT THE RESEARCH DESCRIBED IN ANNEX I , AND ARE PREPARED TO INTEGRATE SUCH RESEARCH INTO A PROCESS OF COORDINATION AT COMMUNITY LEVEL OVER A PERIOD OF THREE YEARS ;   WHEREAS THE EXECUTION OF SUCH RESEARCH AS DESCRIBED IN ANNEX I WILL REQUIRE A FINANCIAL CONTRIBUTION OF ABOUT 850 000 UNITS OF ACCOUNT FROM THE MEMBER STATES ;   WHEREAS THE COMMUNITY IS EMPOWERED TO CONCLUDE AGREEMENTS WITH THIRD COUNTRIES IN THE FIELDS COVERED BY THIS DECISION ; WHEREAS IT MAY PROVE ADVISABLE TO EXTEND THE COORDINATION ESTABLISHED BY THIS DECISION TO THIRD COUNTRIES PARTICIPATING IN EUROPEAN COOPERATION IN THE FIELD OF SCIENTIFIC AND TECHNICAL RESEARCH ( COST ); WHEREAS , ON THE ONE HAND , PROCEDURAL CONDITIONS SHOULD BE DETERMINED SO AS TO LEAD TO A RAPID CONCLUSION OF THESE AGREEMENTS AND , ON THE OTHER , NEGOTIATIONS SHOULD BE OPENED WITH THE COUNTRIES REFERRED TO AS SOON AS THIS DECISION IS ADOPTED ;   WHEREAS THE TREATY HAS NOT PROVIDED THE SPECIFIC POWERS FOR THIS PURPOSE ;   WHEREAS THE SCIENTIFIC AND TECHNICAL RESEARCH COMMITTEE  ( CREST ) HAS GIVEN ITS OPINION ON THE COMMISSION PROPOSAL ,   HAS DECIDED AS FOLLOWS :   ARTICLE 1   THE COMMUNITY SHALL IMPLEMENT FOR A PERIOD OF THREE YEARS A CONCERTED PROJECT IN THE FIELD OF REGISTRATION OF CONGENITAL ABNORMALITIES , HEREINAFTER REFERRED TO AS ' THE PROJECT ' .   THE PROJECT SHALL CONSIST IN COORDINATION AT COMMUNITY LEVEL OF THE RESEARCH DESCRIBED IN ANNEX I , WHICH FORMS PART OF THE RESEARCH PROGRAMMES OF THE MEMBER STATES .   ARTICLE 2   THE COMMISSION SHALL BE RESPONSIBLE FOR SUCH COORDINATION .   ARTICLE 3   THE MAXIMUM FINANCIAL CONTRIBUTION BY THE COMMUNITY TO SUCH A PROJECT WILL BE 330 000 UNITS OF ACCOUNT , THE UNIT OF ACCOUNT BEING DEFINED BY THE RELEVANT FINANCIAL REGULATIONS .   ARTICLE 4   TO FACILITATE THE EXECUTION OF THE PROJECT , A CONCERTED ACTION COMMITTEE ON THE REGISTRATION OF CONGENITAL ABNORMALITIES , HEREINAFTER REFERRED TO AS ' THE COMMITTEE ' SHALL BE ESTABLISHED .   A PROJECT LEADER SHALL BE APPOINTED BY THE COMMISSION IN AGREEMENT WITH THE COMMITTEE . HE SHALL , IN PARTICULAR , ASSIST THE COMMISSION IN ITS COODINATING ACTION .   THE TERMS OF REFERENCE AND THE COMPOSITION OF THIS COMMITTEE ARE DEFINED IN ANNEX II .   THE COMMITTEE SHALL DRAW UP ITS RULES OF PROCEDURE . ITS SECRETARIAT WILL BE PROVIDED BY THE COMMISSION .   ARTICLE 5   IN ACCORDANCE WITH A PROCEDURE TO BE ADOPTED BY THE COMMISSION IN AGREEMENT WITH THE COMMITTEE , THE MEMBER STATE PARTICIPATING IN THE PROJECT SHALL EXCHANGE REGULARLY ALL USEFUL INFORMATION CONCERNING THE EXECUTION OF THE RESEARCH COVERED BY THE PROJECT AND FORWARD TO THE COMMISSION ALL INFORMATION THAT MAY BE USEFUL FOR COORDINATION PURPOSES . THEY SHALL ALSO ENDEAVOUR TO PROVIDE THE COMMISSION WITH INFORMATION ON SIMILAR RESEARCH PLANNED OR CARRIED OUT BY BODIES FOR WHICH THEY ARE NOT RESPONSIBLE . THIS INFORMATION SHALL BE TREATED AS CONFIDENIAL IF SO REQUESTED BY THE MEMBER STATE WHICH PROVIDES IT .   THE COMMISSION SHALL PREPARE YEARLY PROGRESS REPORTS ON THE BASIS OF THE INFORMATION SUPPLIED AND SHALL FORWARD THEM TO THE MEMBER STATES AND TO THE EUROPEAN PARLIAMENT .   AT THE END OF THE COORDINATION PERIOD , THE COMMISSION SHALL , IN AGREEMENT WITH THE COMMITTEE , FORWARD TO THE MEMBER STATES AND TO THE EUROPEAN PARLIAMENT A GENERAL REPORT ON THE EXECUTION AND RESULTS OF THE COORDINATION ACTION . THE COMMISSION SHALL PUBLISH THIS REPORT SIX MONTHS AFTER IT HAS BEEN FORWARDED TO THE MEMBER STATES UNLESS A MEMBER STATE OBJECTS . IN THIS CASE THE REPORT SHALL BE DISTRIBUTED , AT THEIR REQUEST , SOLELY TO INSTITUTIONS AND UNDERTAKINGS WHOSE RESEARCH AND PRODUCTION ACTIVITIES JUSTIFY ACCESS TO THE RESULTS OF THE RESEARCH CARRIED OUT UNDER THE PROJECT . THE COMMISSION MAY MAKE PROVISION THAT THE REPORT REMAINS CONFIDENTIAL AND IS NOT DISCLOSED TO THIRD PARTIES .   ARTICLE 6   1 .  IN ACCORDANCE WITH THE PROVISIONS LAID DOWN IN ARTICLE 228 OF THE TREATY ESTABLISHING THE EEC , THE COMMUNITY MAY CONCLUDE AGREEMENTS WITH OTHER STATES INVOLVED IN EUROPEAN COOPERATION IN THE FIELD OF SCIENTIFIC AND TECHNICAL RESEARCH ( COST ) WITH A VIEW TO EXTENDING THE COORDINATION WHICH IS THE SUBJECT OF THIS DECISION TO RESEARCH UNDERTAKEN IN THESE STATES .   2 .  THE COMMISSION IS HEREBY AUTHORIZED TO OPEN NEGOTIATIONS FOR THE CONCLUSION OF AGREEMENTS OF THE TYPE REFERRED TO IN THE PRECEDING PARAGRAPH .   ARTICLE 7   THIS DECISION SHALL COME INTO FORCE ON 1 JANUARY 1978 .   DONE AT BRUSSELS , 13 FEBRUARY 1978 .   FOR THE COUNCIL   THE PRESIDENT   P . DALSAGER ****    ANNEX I   RESEARCH PROGRAMME RELATING TO THE REGISTRATION OF CONGENITAL ABNORMALITIES  ( CONCERTED PROJECT )   THE RESEARCH WILL BE CARRIED OUT WITH THE PURPOSE OF ACQUIRING SCIENTIFIC AND TECHNICAL KNOWLEDGE IN THIS FIELD , SELECTED FOR ITS IMPORTANCE AT COMMUNITY LEVEL .   THE RESEARCH IS EXPECTED TO COVER THE FOLLOWING TOPICS :   1 . REGISTRATION OF CONGENITAL MALFORMATIONS AS WELL AS OF INHERITED BIOCHEMICAL AND CHROMOSOME ABNORMALITIES IN SELECTED REGIONS OF THE COMMUNITY . THE REGISTRATION WILL PROGRESSIVELY EXTEND TO ABNORMALITIES OF THE NERVOUS SYSTEM  ( ANENCEPHALY , SPINA BIFIDA , ETC .), DOWN ' S SYNDROME , GROSS ABNORMALITIES OF THE LIMBS , MULTIPLE ABNORMALITIES , PHENYLKETONURIA AND COELIAC DISEASE .   2 . REGISTRATION OF TWINS AND MULTIPLE PREGNANCIES IN SELECTED REGIONS OF THE COMMUNITY .   3 . RELEVANT METHODOLOGICAL STUDIES IN ORDER TO OBTAIN AN OPTIMAL COORDINATION OF BOTH EXISTING NATIONAL REGISTERS AND REGISTRATION PROCEDURES .   THE COORDINATION WILL INCLUDE THE FOLLOWING REGIONAL REGISTERS OF THE MEMBER STATES :   //  BELGIUM : //  BRUGGE AND HAINAUT . // DENMARK : //  ODENSE . // FRANCE : //  PARIS . // GERMANY : //  HESSEN . // IRELAND : //  DUBLIN AND GALWAY . // ITALY : //  FLORENCE AND ROME . // LUXEMBOURG : //  LUXEMBOURG . // NETHERLANDS : //  LEIDSCHENDAM . // UNITED KINGDOM : //  BELFAST , GLASGOW AND LIVERPOOL . //   THESE COUNTRIES WILL CONTRIBUTE RESEARCH UNDER THE THREE TOPICS MENTIONED ABOVE . ****    ANNEX II   TERMS OF REFERENCE AND COMPOSITION OF THE CONCERTED ACTION COMMITTEE ON THE REGISTRATION OF CONGENITAL ABNORMALITIES   1 . THE COMMITTEE SHALL :   1.1 . CONTRIBUTE TO THE OPTIMUM EXECUTION OF THE PROGRAMME BY GIVING ITS OPINION ON ALL OF ITS ASPECTS ;   1.2 . EVALUATE THE RESULTS AND DRAW CONCLUSIONS AS REGARDS THEIR APPLICATION ;   1.3 . BE RESPONSIBLE FOR THE EXCHANGE OF INFORMATION REFERRED TO IN THE FIRST SUBPARAGRAPH OF ARTICLE 5 ;   1.4 . KEEP ABREAST OF NATIONAL RESEARCH BEING DONE IN THE FIELDS COVERED BY THE CONCERTED PROJECT , AND MORE ESPECIALLY OF SCIENTIFIC AND TECHNICAL DEVELOPMENTS LIKELY TO AFFECT THE EXECUTION OF THE PROJECT ;   1.5 . SUGGEST GUIDELINES TO THE PROJECT LEADER .   2 . THE COMMITTEE ' S REPORTS AND OPINIONS SHALL BE FORWARDED TO THE COMMISSION AND TO THE MEMBER STATES PARTICIPATING IN THE PROJECT . THE COMMISSION SHALL FORWARD THESE OPINIONS TO THE CREST .   3 . THE COMMITTEE SHALL BE COMPOSED OF PERSONS RESPONSIBLE FOR COORDINATING THE NATIONAL CONTRIBUTIONS TO THE PROGRAMME , AND THE PROJECT LEADER . EACH MEMBER MAY BE ACCOMPANIED BY EXPERTS .


Avis juridique important

|

31998D0328

98/328/ECSC: European Parliament Decision of 31 March 1998 giving discharge to the Commission in respect of the management of the ECSC for the financial year 1996

Official Journal L 146 , 16/05/1998 P. 0022 - 0025

EUROPEAN PARLIAMENT DECISION of 31 March 1998 giving discharge to the Commission in respect of the management of the ECSC for the financial year 1996 (98/328/ECSC)THE EUROPEAN PARLIAMENT,- Having regard to the following amounts contained in the financial statements of the ECSC as at 31 December 1996 (1), and the report of the Court of Auditors of 24 June 1997, confirming that the financial statements present a true picture of the financial situation of the European Coal and Steel Community at 31 December 1996, and the results of ECSC operations for the financial year ending on the same date,1. Gives the Commission discharge in respect of the management of the ECSC for the 1996 financial year on the basis of the following figures relating to the implementation of the administrative budget for the 1996 financial year;2. Instructs its President to forward this Decision and the resolution containing its comments to the Commission, the Council, the Court of Auditors and the ECSC Consultative Committee and to have them published in the Official Journal of the European Communities (L series).ECSC balance sheet at 31 December 1996 (All figures in ecus) >TABLE>>TABLE>Profit and loss accounts for year ending 31 December 1996 (All figures in ecus) >TABLE>>TABLE>Implementation of the ECSC operating budget (All figures in ecus) >TABLE>>TABLE>The Secretary-GeneralJulian PRIESTLEYThe PresidentJosé María GIL-ROBLES(1) JO C 242, 8. 8. 1997, pp. 7 and 32.


Avis juridique important

|

31981D0021

81/21/EEC: Council Decision of 20 January 1981 amending Decision 78/167/EEC adopting a concerted project of the European Economic Community in the field of registration of congenital abnormalities (medical and public health research)

Official Journal L 043 , 14/02/1981 P. 0012 - 0013

++++COUNCIL DECISION  OF 20 JANUARY 1981  AMENDING DECISION 78/167/EEC ADOPTING A CONCERTED PROJECT OF THE EUROPEAN ECONOMIC COMMUNITY IN THE FIELD OF REGISTRATION OF CONGENITAL ABNORMALITIES ( MEDICAL AND PUBLIC HEALTH RESEARCH )   ( 81/21/EEC )  THE COUNCIL OF THE EUROPEAN COMMUNITIES ,  HAVING REGARD TO THE TREATY ESTABLISHING THE EUROPEAN ECONOMIC COMMUNITY , AND IN PARTICULAR ARTICLE 235 THEREOF ,  HAVING REGARD TO THE PROPOSAL FROM THE COMMISSION ,  HAVING REGARD TO THE OPINION OF THE EUROPEAN PARLIAMENT ( 1 ) ,  WHEREAS BY DECISION 78/167/EEC ( 2 ) THE COUNCIL ADOPTED A CONCERTED PROJECT OF THE EUROPEAN ECONOMIC COMMUNITY IN THE FIELD OF REGISTRATION OF CONGENITAL ABNORMALITIES  ( MEDICAL AND PUBLIC HEALTH RESEARCH ) ;  WHEREAS , IN VIEW OF THE CURRENT STAGE REACHED IN THE WORK PROVIDED FOR UNDER THE CONCERTED PROJECT , AN EXTENSION OF THE SAID PROJECT BY ONE YEAR WOULD ENABLE THE BEST ADVANTAGE TO BE OBTAINED FROM THE NATIONAL EFFORTS BEING MADE ; WHEREAS DECISION 78/167/EEC SHOULD THEREFORE BE AMENDED ,  HAS DECIDED AS FOLLOWS :  SOLE ARTICLE  DECISION 78/167/EEC SHALL BE AMENDED AS FOLLOWS :   ( 1 ) IN THE FIRST PARAGRAPH OF ARTICLE 1 THE TERM  " A PERIOD OF THREE YEARS " SHALL BE REPLACED BY " A PERIOD OF FOUR YEARS " ;   ( 2 ) ANNEX I SHALL BE REPLACED BY THE ANNEX TO THIS DECISION .  DONE AT BRUSSELS , 20 JANUARY 1981 .  FOR THE COUNCIL  THE PRESIDENT  CH . A . VAN DER KLAAUW  ( 1 ) OJ NO C 346 , 31 . 12 . 1980 , P . 95 .  ( 2 ) OJ NO L 52 , 23 . 2 . 1978 , P . 20 .  ANNEX   " ANNEX I  RESEARCH PROGRAMME RELATING TO THE REGISTRATION OF CONGENITAL ABNORMALITIES   ( CONCERTED PROJECT )  THE RESEARCH WILL BE CARRIED OUT WITH THE PURPOSE OF ACQUIRING SCIENTIFIC AND TECHNICAL KNOWLEDGE IN THIS FIELD , SELECTED FOR ITS IMPORTANCE AT COMMUNITY LEVEL .  THE RESEARCH IS EXPECTED TO COVER THE FOLLOWING TOPICS :  1 . REGISTRATION OF CONGENITAL MALFORMATIONS AS WELL AS OF INHERITED BIOCHEMICAL AND CHROMOSOME ABNORMALITIES IN SELECTED REGIONS OF THE COMMUNITY .  2 . REGISTRATION OF TWINS AND MULTIPLE PREGNANCIES IN SELECTED REGIONS OF THE COMMUNITY .  3 . RELEVANT METHODOLOGICAL STUDIES IN ORDER TO OBTAIN AN OPTIMAL COORDINATION OF BOTH EXISTING NATIONAL REGISTERS AND REGISTRATION PROCEDURES .  THE COORDINATION WILL INCLUDE THE FOLLOWING REGIONAL REGISTERS OF THE MEMBER STATES :  BELGIUM : BRUGGE AND HAINAUT  DENMARK : ODENSE  FRANCE : PARIS AND MORLAIX  GERMANY : WEST BERLIN AND HESSEN  GREECE : EVIA  IRELAND : DUBLIN AND GALWAY  ITALY : TUSCANY , ROME AND EMILIA-ROMAGNA  LUXEMBOURG : LUXEMBOURG  NETHERLANDS : GRONINGEN  UNITED KINGDOM : BELFAST , GLASGOW AND LIVERPOOL .  THESE COUNTRIES WILL CONTRIBUTE RESEARCH UNDER THE THREE TOPICS MENTIONED ABOVE . "


title: Council Decision (CFSP) 2017/1385 of 25 July 2017 amending Decision (CFSP) 2015/778 on a European Union military operation in the Southern Central Mediterranean (EUNAVFOR MED operation SOPHIA)

text:
               26.7.2017

               EN

               Official Journal of the European Union

               L 194/61

         COUNCIL DECISION (CFSP) 2017/1385
   of 25 July 2017
   amending Decision (CFSP) 2015/778 on a European Union military operation in the Southern Central Mediterranean (EUNAVFOR MED operation SOPHIA)
   THE COUNCIL OF THE EUROPEAN UNION,
   Having regard to the Treaty on European Union, and in particular Articles 42(4) and 43(2) thereof,
   Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,
   Whereas:

               (1)

               On 18 May 2015, the Council adopted Decision (CFSP) 2015/778 (1).

               (2)

               On 20 June 2016, the Council adopted Decision (CFSP) 2016/993, (2) which amended Decision (CFSP) 2015/778 by extending the operation's mandate until 27 July 2017 and by adding two supporting tasks to EUNAVFOR MED operation SOPHIA's mandate, namely capacity building and training of the Libyan Coastguard and Navy, and contributing to information sharing and to the implementation of the UN arms embargo on the high seas off the coast of Libya.

               (3)

               On 19 December 2016, the Council adopted Decision (CFSP) 2016/2314, (3) which enhanced the authorisations granted to EUNAVFOR MED operation SOPHIA to exchange information with relevant actors.

               (4)

               On 3 February 2017, the Malta Declaration by the members of the European Council on the external aspects of migration: addressing the Central Mediterranean route affirmed that priority will notably be given to training, equipment and support to the Libyan national Coast Guard and other relevant agencies and to further efforts to disrupt the business model of smugglers through enhanced operational action, within an integrated approach involving Libya and other countries on the route as well as relevant international partners, engaged Member States, CSDP missions and operations, Europol and the European Border and Coast Guard Agency (Frontex).

               (5)

               On 6 February 2017, in its conclusions on Libya, the Council stated that EUNAVFOR MED operation SOPHIA will continue to focus on disrupting the business model of human smuggling and trafficking networks; in addition, it will continue to implement its two supporting tasks.

               (6)

               The contribution by EUNAVFOR MED operation SOPHIA to information sharing may also contribute to implementing UN Security Council Resolutions (‘UNSCR’) 2146 (2014) and UNSCR 2362 (2017).

               (7)

               On 12 June 2017, by UNSCR 2357 (2017), the UN Security Council renewed the authorisations granted by UNSCR 2292 (2016), which concerns the strict implementation of the arms embargo on the high seas off the coast of Libya.

               (8)

               On 23 June 2017, the European Council notably underlined in its conclusions that the disruption of the business model of human smugglers and traffickers remains a key objective, and that training and equipping the Libyan Coast Guard is a key component of the EU approach in this regard.

               (9)

               On 4 July 2017, based on the strategic review of the operation, the Political and Security Committee agreed to extend the mandate of EUNAVFOR MED operation SOPHIA until 31 December 2018.

               (10)

               Decision (CFSP) 2015/778 should be amended accordingly.

               (11)

               In accordance with Article 5 of Protocol No 22 on the position of Denmark annexed to the TEU and to the Treaty on the Functioning of the European Union (TFEU), Denmark does not participate in the elaboration and implementation of decisions and actions of the Union which have defence implications. Consequently, Denmark is not participating in the adoption of this Decision, is neither bound by it nor subject to its application, and does not participate in the financing of this operation,

         HAS ADOPTED THIS DECISION:
   Article 1
   Decision (CFSP) 2015/778 is amended as follows:

               (1)

               In Article 2(4), the last sentence is replaced by the following:
               ‘It may transmit such data as well as data related to the vessels and equipment used by such persons, and the relevant information acquired while carrying out this core task, to the relevant law enforcement authorities of Member States and to competent Union bodies.’.

               (2)

               In Article 2a, the following paragraph is added:
               ‘4a.   For the purpose of the supporting task referred to in paragraph 1, a monitoring mechanism shall be established in close coordination with other relevant stakeholders.’.

               (3)

               In Article 2b, the following paragraph is added:
               ‘4.   In addition, in the Area of Operation, and within its means and capabilities, EUNAVFOR MED operation SOPHIA shall conduct surveillance activities and gather information on illegal trafficking, including information on crude oil and other illegal exports that are contrary to UNSCR 2146 (2014) and UNSCR 2362 (2017), thereby contributing to situational awareness and to maritime security in the Central Mediterranean. The information gathered in this context may be released to the legitimate Libyan authorities and to the relevant law enforcement authorities of Member States and to competent Union bodies.’.

               (4)

               In Article 11, the following paragraph is added:
               ‘4.   For the period 28 July 2017 to 31 December 2018, the reference amount for the common costs of EUNAVFOR MED operation SOPHIA shall be EUR 6 000 000. The percentage of the reference amount referred to in Article 25(1) of Decision (CFSP) 2015/528 shall be 0 % both in commitments and payments.’.

               (5)

               In Article 13, the second paragraph is replaced by the following:
               ‘EUNAVFOR MED operation SOPHIA shall end on 31 December 2018.’.

         Article 2
   This Decision shall enter into force on the date of its adoption.

      Done at Brussels, 25 July 2017.

            For the Council

            The President

         M. MAASIKAS

      (1)  Council Decision (CFSP) 2015/778 of 18 May 2015 on a European Union military operation in the Southern Central Mediterranean (EUNAVFOR MED operation SOPHIA) (OJ L 122, 19.5.2015, p. 31).

      (2)  Council Decision (CFSP) 2016/993 of 20 June 2016 amending Decision (CFSP) 2015/778 on a European Union military operation in the Southern Central Mediterranean (EUNAVFOR MED operation SOPHIA) (OJ L 162, 21.6.2016, p. 18).

      (3)  Council Decision (CFSP) 2016/2314 of 19 December 2016 amending Decision (CFSP) 2015/778 on a European Union military operation in the Southern Central Mediterranean (EUNAVFOR MED operation SOPHIA) (OJ L 345, 20.12.2016, p. 62).


Avis juridique important

|

31981D1032

81/1032/EEC: Council Decision of 7 December 1981 adopting a multi-annual research and training programme for the European Economic Community in the field of biomolecular engineering (indirect action April 1982 to March 1986)

Official Journal L 375 , 30/12/1981 P. 0001 - 0004 Spanish special edition: Chapter 16 Volume 1 P. 0080  Portuguese special edition Chapter 16 Volume 1 P. 0080

+++++( 1 ) OJ NO C 327 , 15 . 12 . 1980 , P . 37 .  ( 2 ) OJ NO C 230 , 8 . 9 . 1980 , P . 11 .  ( 3 ) OJ NO C 7 , 29 . 1 . 1974 , P . 6 .  ( 4 ) OJ NO C 192 , 11 . 8 . 1977 , P . 1 .  ( 5 ) OJ NO L 255 , 20 . 9 . 1974 , P . 1 .  COUNCIL DECISION OF 7 DECEMBER 1981 ADOPTING A MULTI-ANNUAL RESEARCH AND TRAINING PROGRAMME FOR THE EUROPEAN ECONOMIC COMMUNITY IN THE FIELD OF BIOMOLECULAR ENGINEERING ( INDIRECT ACTION APRIL 1982 TO MARCH 1986 ) ( 81/1032/EEC )  THE COUNCIL OF THE EUROPEAN COMMUNITIES ,  HAVING REGARD TO THE TREATY ESTABLISHING THE EUROPEAN ECONOMIC COMMUNITY , AND IN PARTICULAR ARTICLE 235 THEREOF ,  HAVING REGARD TO THE PROPOSAL FROM THE COMMISSION ,  HAVING REGARD TO THE OPINION OF THE EUROPEAN PARLIAMENT ( 1 ) ,  HAVING REGARD TO THE OPINION OF THE ECONOMIC AND SOCIAL COMMITTEE ( 2 ) ,  WHEREAS ARTICLE 2 OF THE TREATY ASSIGNS TO THE COMMUNITY INTER ALIA THE TASK OF PROMOTING THROUGHOUT THE COMMUNITY A HARMONIOUS DEVELOPMENT OF ECONOMIC ACTIVITIES , A CONTINUOUS AND BALANCED EXPANSION AND AN ACCELERATED RAISING OF THE STANDARD OF LIVING ;  WHEREAS IN ITS RESOLUTION OF 14 JANUARY 1974 ON AN INITIAL OUTLINE PROGRAMME OF THE EUROPEAN COMMUNITIES IN THE FIELD OF SCIENCE AND TECHNOLOGY ( 3 ) , THE COUNCIL STATED THAT THE WHOLE RANGE OF AVAILABLE WAYS AND MEANS SHOULD BE USED AS APPROPRIATE , INCLUDING INDIRECT ACTION ;  WHEREAS A COMMUNITY RESEARCH AND TRAINING PROGRAMME IN THE FIELD OF BIOMOLECULAR ENGINEERING IS NECESSARY FOR THE ACHIEVEMENT OF THE ABOVEMENTIONED OBJECTIVES AND , PARTICULARLY , FOR THE DEVELOPMENT OF NEW TECHNOLOGIES LEADING TO :  - THE DEVELOPMENT OF IMPROVED AGRICULTURAL AND BIO-INDUSTRIAL PRODUCTS ,  - THE DETERMINATION OF MORE EFFICIENT AND SAFER PRODUCTION METHODS ,  - REDUCED ENERGY CONSUMPTION AND IMPROVEMENTS IN THE BALANCE OF PAYMENTS ;  WHEREAS IT IS NECESSARY TO UNDERTAKE EXPERIMENTS FOR ASSESSING POSSIBLE BIOHAZARDS ASSOCIATED WITH APPLICATIONS IN AGRICULTURE AND INDUSTRY OF BIOMOLECULAR ENGINEERING AND TO ORGANIZE COURSES IN GOOD MICROBIOLOGICAL PRACTICE ;  WHEREAS TRAINING INCENTIVES ARE ESSENTIAL FOR THE EXPLOITATION OF BIOTECHNOLOGY BY AGRICULTURE AND INDUSTRY ;  WHEREAS IT IS ADVISABLE TO PROMOTE THE MOBILITY OF PERSONNEL BETWEEN THE ORGANIZATIONS COLLABORATING IN THE IMPLEMENTATION OF THIS PROGRAMME ;  WHEREAS THE TREATY HAS NOT PROVIDED THE NECESSARY SPECIFIC POWERS ;  WHEREAS ACCOUNT SHOULD BE TAKEN OF THE OPINION OF THE SCIENTIFIC AND TECHNICAL RESEARCH COMMITTEE ( CREST ) ON THE COMMISSION PROPOSAL ,  HAS DECIDED AS FOLLOWS :  ARTICLE 1  A BIOMOLECULAR ENGINEERING RESEARCH AND TRAINING PROGRAMME ( HEREINAFTER CALLED " THE PROGRAMME " ) FOR THE EUROPEAN ECONOMIC COMMUNITY IS HEREBY ADOPTED IN THE FORM SET OUT IN THE ANNEX FOR A FOUR-YEAR PERIOD STARTING ON 1 APRIL 1982 .  ARTICLE 2  THE COMMISSION SHALL BE RESPONSIBLE FOR THE IMPLEMENTATION OF THIS PROGRAMME WHICH SHALL BE IMPLEMENTED IN TWO STAGES . THE FIRST STAGE SHALL RUN FROM 1 APRIL 1982 UNTIL THE REVISION PROVIDED FOR IN ARTICLE 5 AND THE SECOND FROM THIS REVISION UNTIL 31 MARCH 1986 .  ARTICLE 3  THE APPROPRIATIONS CURRENTLY ALLOCATED FOR THE EXECUTION OF THE ALREADY AGREED PROGRAMME , THE AMOUNT OF WHICH IS FIXED AT 8 MILLION ECU , INCLUDING EXPENDITURE ON A STAFF OF THREE , SHALL BE ENTERED IN THE BUDGET OF THE EUROPEAN COMMUNITIES .  THE AMOUNT OF THE APPROPRIATIONS AND THE STAFF REQUIRED TO EXECUTE THE PROGRAMME SHALL BE RE-EVALUATED WHEN THE PROGRAMME IS REVISED AS PROVIDED FOR IN ARTICLE 5 .  ARTICLE 4  IN ORDER TO ASSIST THE COMMISSION IN IMPLEMENTING THIS PROGRAMME , THERE IS HEREBY ESTABLISHED AN ADVISORY COMMITTEE FOR THE MANAGEMENT OF THE RESEARCH AND TRAINING PROGRAMME IN THE FIELD OF BIOMOLECULAR ENGINEERING , WHOSE TERMS OF REFERENCE CONFORM TO THE COUNCIL RESOLUTION OF 18 JULY 1977 ( 4 ) .  ARTICLE 5  THE PROGRAMME SHALL BE SUBJECT TO REVISION DURING THE SECOND YEAR IN ACCORDANCE WITH APPROPRIATE PROCEDURES AFTER CONSULTATION WITH THE COMMITTEE REFERRED TO IN ARTICLE 4 . THE DECISION TO REVISE THE PROGRAMME SHALL BE TAKEN NOT LATER THAN 31 MARCH 1984 .  ARTICLE 6  INFORMATION RESULTING FROM THE IMPLEMENTATION OF THE PROGRAMME SHALL BE DISSEMINATED IN ACCORDANCE WITH REGULATION ( EEC ) NO 2380/74 ( 5 ) .  DONE AT BRUSSELS , 7 DECEMBER 1981 .  FOR THE COUNCIL  THE PRESIDENT  CARRINGTON  ANNEX  BIOMOLECULAR ENGINEERING PROGRAMME  1 . DEVELOPMENT OF NEW REACTORS USING IMMOBILIZED MULTIENZYME SYSTEMS INCLUDING THOSE REQUIRING MULTIPHASE ENVIRONMENT AND COFACTOR REGENERATION  SPECIAL EMPHASIS WILL BE PLACED ON THE DEVELOPMENT OF NEW PROCEDURES FOR THE IMMOBILIZATION OF :  ( A ) SINGLE ENZYMES OR COMBINATIONS OF ENZYMES ABLE TO SYNTHESIZE FINE CHEMICALS OF HIGH ADDED VALUE WITH SPECIAL REFERENCE TO COFACTOR REGENERATION AND STABILIZATION OF ENZYMES IN NON-AQUEOUS OR MULTIPHASE ENVIRONMENT . KINETIC STUDIES OF THE FLOW OF MATTER IN REACTORS USING THESE NEW SYSTEMS WILL ALSO BE PROMOTED ;  ( B ) CELLS WITH PARTICULAR REFERENCE TO PLANT , YEAST AND MAMMALIAN CELLS ;  ( C ) SUBCELLULAR ORGANELLES SUCH AS PEROXISOMES , CHLOROPLASTS , MITOCHONDRIA , MICROSOMES .  2 . DEVELOPMENT OF BIOREACTORS FOR HUMAN DETOXIFICATION  DEVELOPMENT OF NEW PROCEDURES USING IMMOBILIZED ENZYMES FOR THE REMOVAL OF TOXIC SUBSTANCES FROM THE HUMAN BODY WITH SPECIAL REFERENCE TO THE DEVELOPMENT OF BIOCOMPATIBLE ENZYME SUPPORTS ( E . G . NON-TOXIC , IMMUNOCOMPATIBLE , THROMBOCOMPATIBLE , BIODEGRADABLE ) AND OF CARRIERS PROVIDED WITH SPECIAL SENSORS AND TROPISMS FOR TARGETING EXOGENOUS ENZYMES .  3 . THE TRANSFER OF GENES FROM DIVERSE SOURCES TO THE BACTERIUM ESCHERICHIA COLI , THE YEAST SACCHAROMYCES CEREVISIAE AND OTHER SUITABLE ORGANISMS  THE ORIENTATION IN THIS PROJECT WILL HAVE SPECIAL REFERENCE TO :  ( A ) THE CHEMICAL CONSTRUCTION OF " SYNTHETIC GENES " ;  ( B ) DEVELOPMENT OF MUTATIONAL TOOLS ( E . G . SITE SPECIFIC MUTAGENESIS ) ;  ( C ) OVERCOMING THE EXPRESSION BARRIERS FOR PARTICULAR PROTEINS ;  ( D ) MODIFICATION TO INHIBIT THE DEGRADATION OF ENZYMES IN A FOREIGN ENVIRONMENT BY SUCH TECHNIQUES AS REPRESSION OF PROTEOLYTIC ACTIVITY OF THE HOST CELL OR BY TAGGING THE DESIRED PROTEIN TO ANOTHER WHICH IS EXCRETED EXTRACELLULARLY ;  ( E ) POST-TRANSLATIONAL MODIFICATION , E . G . GLYCOSYLATION ;  ( F ) THE POSSIBILITY OF SUPPORTING THE COLLECTION AND STORAGE ( E . G . AS MRNA OR CLONED IN PLASMIDS ) FOR DISTRIBUTION TO RELEVANT LABORATORIES IN THE COMMUNITY OF RARE MATERIAL SUCH AS TUMOURS CAPABLE OF SYNTHESIZING ABNORMALLY HIGH QUANTITIES OF SPECIFIC HORMONES .  4 . DEVELOPMENT OF CLONING SYSTEMS  ALTHOUGH CLONING OF FOREIGN GENES IN THE BACTERIUM ESCHERICHIA COLI IS NOW ROUTINELY PERFORMED IN MANY LABORATORIES , LITTLE HAS BEEN ACHIEVED ON THE CLONING AND EXPRESSION IN OTHER ORGANISMS WHICH ARE LIKELY TO BE OF GREAT IMPORTANCE TO EUROPEAN INDUSTRY AND AGRICULTURE . THE FIRST STEP IS THE DEVELOPMENT OF PRACTICALLY APPLICABLE VECTORS IN A WIDE RANGE OF DIFFERENT VIRUSES , BACTERIA , FUNGI , ALGAE , PLANTS AND ANIMALS . THE STABILITY , REGULATION AND EXPRESSION OF TRANSFERRED GENES WILL BE STUDIED WITHIN THE FRAMEWORK OF THIS PROJECT AND OF PROJECTS 3 AND 5 .  5 . GENE TRANSFER IN MICRO-ORGANISMS AND IN PLANTS IMPORTANT TO AGRICULTURE  ( A ) THE DEVELOPMENT AND IMPROVEMENT OF METHODS FOR INTRODUCING , WHEN CONSIDERED NECESSARY FOR AGRICULTURAL PURPOSES , FOREIGN GENETIC INFORMATION IN MICRO-ORGANISMS AND IN PLANTS WHICH PLAY AN IMPORTANT ROLE IN EUROPEAN AGRICULTURE . ALL METHODS LIKELY TO ALLOW THE TRANSFER OF GENES BETWEEN SPECIES WHICH NORMALLY DO NOT EXCHANGE GENETIC INFORMATION IN NATURE ARE TO BE CONSIDERED IN THIS SUBPROJECT . PARTICULAR ATTENTION IS TO BE GIVEN , HOWEVER , TO MODERN TECHNIQUES , INCLUDING SOMATIC CELL HYBRIDIZATION , THE TRANSFER OF INDIVIDUAL CHROMOSOMES AND THE DEVELOPMENT OF CLONING SYSTEMS AND THEIR EXPLOITATION .  ( B ) ANALYSIS AND CONTROL OF THE STABILITY , REGULATION AND EXPRESSION OF TRANSFERRED GENES .  ( C ) ANALYSIS AND CONTROL OF PLANT REGENERATION IN VITRO , I . E . THE PRODUCTION OF DIFFERENTIATED ORGANISMS FROM ISOLATED CELLS CULTURED IN VITRO , A STEP WHICH CONSTITUTES ONE OF THE FIRST CONDITIONS FOR THE SUCCESS OF ANY PROJECT BASED UPON RECOMBINANT DNA TECHNOLOGY OR SOMATIC HYBRIDIZATION FOR THE IMPROVEMENT OF CULTIVATED PLANTS .  6 . IMPROVEMENT OF METHODS FOR DETECTING CONTAMINATION AND FOR THE ASSESSMENT OF POSSIBLE RISKS ASSOCIATED WITH APPLICATIONS IN AGRICULTURE AND INDUSTRY OF BIOMOLECULAR ENGINEERING  ( A ) IMPROVEMENT OF METHODS FOR DETECTING CONTAMINATION ( INCLUDING MUTATIONS AND PHAGE - OR PLASMID-MODIFIED VARIATIONS OF THE PROCESS STRAIN ) .  ( B ) DEVELOPMENT OF A PROCEDURE FOR ASSESSING THE RISKS WHICH MIGHT RESULT FROM THE EXPERIMENTAL OR INDUSTRIAL USE OF MICRO-ORGANISMS AND FROM LARGE-SCALE APPLICATIONS OF BIOMOLECULAR ENGINEERING .